Role Of Rising Chronic Disease Incidence In Driving Growth Of The Narcotic Drug Market Driving Market Acceleration in the Narcotic Drugs Industry, 2025

"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Narcotic Drugs Market Size By 2025?
In recent times, there has been stable growth in the market size of narcotic drugs. An elevation from $14.26 billion in 2024 to $14.71 billion in 2025, amounting to a compound annual growth rate (CAGR) of 3.1%, is predicted. The significant growth during the historical phase can be credited to the mounting medical necessity, escalating public health apprehensions, enhanced access to healthcare, increasing instances of chronic pain, and government efforts to ameliorate pain management.

How Big Is the Narcotic Drugs Market Size Expected to Grow by 2029?
Anticipated expansion in the narcotic drugs market is projected to experience a steady rise in the upcoming years, increasing to ""$17.67 billion in 2029"" with a compound annual growth rate (CAGR) of 4.7%. This predicted growth over the forecasted period is owed to factors such as a surging demand for generic narcotic drugs, an escalating pharmaceutical industry, an increased interest in minimally invasive surgeries, and the growing usage of narcotic drugs in palliative care. The forthcoming period is also likely to witness trends such as innovation within the pharmaceutical industry, telemedicine and remote monitoring, the creation of non-opioid alternatives, and the application of artificial intelligence (AI) in the discovery and development of drugs.

View the full report here:
https://www.thebusinessresearchcompany.com/report/narcotic-drugs-global-market-report

Which Key Market Drivers Powering Narcotic Drugs Market Expansion and Growth?
The growth of the narcotic drug market is expected to be driven by the increasing prevalence of chronic diseases. Chronic illness extends for three months or more and can worsen over time. Narcotic drugs are administered to alleviate symptoms of chronic diseases such as cancer, chronic pain syndrome, terminal disease, and severe arthritis. For example, in June 2024, the National Health Service, a government department based in the UK, found that in 2023, over half a million (549,000) more individuals in England were at risk of developing type 2 diabetes, totaling the number of people with non-diabetic hyperglycemia, also known as pre-diabetes, registered with a GP to 3,615,330. This marks a substantial growth from 3,065,825 in 2022, indicating an increase of almost 20%. As such, the growing prevalence of chronic diseases is a key driver for the expansion of the narcotic drug market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12863&type=smp

What Are the Key Trends Driving Narcotic Drugs Market Growth?
In a bid to bolster their market standing, prominent firms in the narcotic drug sector are increasingly centering their operations on product development and innovation. This is aimed at offering dependable products to their clientele. A case in point is Indivior PLC, a pharmaceutical firm based in the US, which in May 2023, unveiled OPVEE (nalmefene) nasal spray. This is a life-saving medication used in cases of opioid overdoses from natural and synthetic opioids like fentanyl. It is advised for immediate use in confirmed or suspected cases of opioid overdoses in both adults and pediatric patients aged 12 years and above, as evidenced by respiratory and central nervous system depression.

What Are the Emerging Segments in the Narcotic Drugs Market?
The narcotic drugs market covered in this report is segmented -

1) By Drug: Opi*um, Her*oin, Codeine, Oxycodone, Other Drugs
2) By Source: Natural, Semi-Synthetic, Synthetic
3) By Indication: Pain Management, Cough, Diarrhea, Dysentery, Asthma, Other Indications
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:
1) By Op*ium: Raw Opi*um, Op*ium Extracts, Op*ium Derivatives
2) By Her*oin: Diacetylmorphine, Her*oin Hydrochloride, He*roin Acetate
3) By Codeine: Codeine Phosphate, Codeine Sulfate
4) By Oxycodone: Oxycodone Hydrochloride, Oxycodone Acetaminophen, Controlled-Release Oxycodone
5) By Other Drugs: Fentanyl, Morphine, Hydromorphone, Methadone, Buprenorphine

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12863&type=smp

Who Are the Global Leaders in the Narcotic Drugs Market?
Major companies operating in the narcotic drugs market are Pfizer Inc., Johnson and Johnson Limited, AbbVie Inc., Novartis AG, AstraZeneca PLC, Sanofi S.A., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Purdue Pharma LP, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Lupin Ltd., Mallinckrodt Pharmaceuticals, Alvogen Inc., Indivior Inc., Impax Laboratories Inc., Collegium Pharmaceutical Inc., Lannett Co Inc., Par Pharmaceutical Inc., West-Ward Pharmaceuticals Corp.

Which are the Top Profitable Regional Markets for the Narcotic Drugs Industry?
Asia-Pacific was the largest region in the narcotic drugs market in 2024. The regions covered in the narcotic drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12863

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.